share_log
Moomoo 24/7 ·  Apr 15 07:00
TFF Pharmaceuticals Announces Additional Positive Data From the Tacrolimus Inhalation Powder (TFF Tac) Phase 2 Trial Following Oral Presentation at the Ishlt 44TH Annual Late Breaking Clinical Science Abstract Sessions
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment